10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 18, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2019 | Dec 31, 2018 | |
| Assets: | ||
| Cash and cash equivalents | $ 5,683 | 4,059 |
| Investments | 2,373 | 2,522 |
| Accounts receivable, net | 19,617 | 17,631 |
| Inventories | 17,516 | 16,450 |
| Other current assets | 5,113 | 4,581 |
| Total current assets | 50,302 | 45,243 |
| Long-term investments | 17,314 | 15,732 |
| Property and equipment, net | 12,044 | 11,360 |
| Property and equipment, net | 11,349 | |
| Operating lease right-of-use assets | 20,860 | 20,987 |
| Goodwill | 79,749 | 78,678 |
| Intangible assets, net | 33,121 | 36,524 |
| Separate accounts assets | 4,459 | 3,884 |
| Other assets | 4,600 | 5,046 |
| Total assets | 222,449 | 196,456 |
| Liabilities: | ||
| Accounts payable | 10,492 | 8,925 |
| Pharmacy claims and discounts payable | 13,601 | 11,365 |
| Health care costs payable | 6,879 | 6,147 |
| Policyholders funds | 2,991 | 2,939 |
| Accrued expenses | 12,133 | 10,711 |
| Other insurance liabilities | 1,830 | 1,937 |
| Current portion of operating lease liabilities | 1,596 | 1,803 |
| Short-term debt | 0 | 720 |
| Current portion of long-term debt | 3,781 | 1,265 |
| Total current liabilities | 53,303 | 44,009 |
| Long-term operating lease liabilities | 18,926 | 18,832 |
| Long-term debt | 64,699 | 71,444 |
| Deferred income taxes | 7,294 | 7,677 |
| Separate accounts liabilities | 4,459 | 3,884 |
| Other long-term insurance liabilities | 7,436 | 8,119 |
| Other long-term liabilities | 2,162 | 2,780 |
| Total liabilities | 158,279 | 137,913 |
| Commitments and contingencies (Note 16) | ||
| Shareholders equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | 0 |
| Common stock, par value $0.01: 3,200 shares authorized; 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus | 45,972 | 45,440 |
| Treasury stock, at cost: 425 shares at both December 31, 2019 and 2018 | (28,235) | (28,228) |
| Retained earnings | 45,108 | 40,911 |
| Accumulated other comprehensive income | 1,019 | 102 |
| Total CVS Health shareholders equity | 63,864 | 58,225 |
| Noncontrolling interests | 306 | 318 |
| Total shareholders equity | 64,170 | 58,543 |
| Total liabilities and shareholders equity | 222,449 | 196,456 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |